Table 2 Summary of clinical and demographic data for the set of Caucasian IBD patients
CD n (%) | UC n (%) | IC n (%) | |
|---|---|---|---|
Gender | |||
Female | 249 (64.2) | 214 (52.8) | 15 (55.6) |
Male | 139 (35.8) | 191 (47.2) | 12 (44.4) |
Age at first diagnosis | |||
Below 17 | 39 (10.0) | 26 (6.4) | 0 |
Between 17 and 40 | 199 (51.3) | 184 (45.4) | 15 (55.6) |
Above 40 | 150 (38.7) | 195 (48.2) | 12 (44.4) |
CD location | |||
Ileal | 125 (32.2) | ||
Colonic | 169 (43.6) | ||
Ileocolonic | 90 (23.2) | ||
Upper GI | 4 (1.0) | ||
UC location | |||
Proctitis | 140 (34.6) | 3 (11.1) | |
Left colon | 107 (26.4) | 5 (18.5) | |
Pancolitis | 154 (38.0) | 19 (70.4) | |
Unknown | 4 (1.0) | 0 | |
Behaviour | |||
Non-stricturing, non-penetrating perianal disease | 47 (21.5) | ||
Stricturing perianal disease | 46 (38.0) | ||
Penetrating perianal disease | 17 (35.4) | ||
Any relative with IBD: Yes (n = 143) | 74 (19.1) | 65 (16.1) | 5 (18.5) |
Bowel resection: Yes (n = 214) | 142 (36.6) | 70 (17.3) | 2 (7.4) |
Smoker at diagnosis: Yes (n = 147) | 97 (25.7) | 49 (12.3) | 2 (7.7) |
Ever used immunomodulators: Yes (n = 296) | 203 (52.3) | 86 (21.2) | 8 (29.6) |
Extraintestinal manifestations: Yes (n = 142) | 75 (19.3) | 64 (15.8) | 3 (11.1) |